Ranbaxy Laboratories Limited

218 articles about Ranbaxy Laboratories Limited

• FDA Raises More Concerns About Ranbaxy Laboratories's India Plants, Shares Fall

  1/13/2014

• EPIRUS Biopharmaceuticals And Ranbaxy Laboratories Announce Signing Of BOW015 Licensing Partnership For Broad Range Of Territories

  1/8/2014

• Daiichi Sankyo, Inc. To Help Ranbaxy Laboratories Meet FDA Norms

  12/19/2013

• Notices Sent To Ranbaxy Laboratories, Cipla Ltd. For Overcharging

  12/10/2013

• Ranbaxy Laboratories May Sell Off Biovel, Exit Vaccine Business

  11/25/2013

• Singh Brothers Of Ranbaxy Laboratories Concealed Facts While Selling Stake: Daiichi Sankyo, Inc.

  11/11/2013

• No Criminal Case Against Ranbaxy Laboratories, Daiichi Sankyo, Inc.

  11/1/2013

• Ranbaxy Laboratories, Wockhardt Fire 5 Percent of Shopfloor Workforce: FDA Ban's Side Effects

  10/21/2013

• Ranbaxy Laboratories Jumps as US Plant Wins FDA Clearance

  10/11/2013

• Ranbaxy Laboratories Denies Plans to Reduce Workforce

  10/3/2013

• What Hurt Ranbaxy Laboratories? Hair, Oil Spots and Bathrooms Without Water

  9/19/2013

• Ranbaxy Laboratories Crashes on FDA Import Alert for Mohali Unit; Stock Falls -30.27% at Market Close (September 16, 2013)

  9/16/2013

• Ranbaxy Laboratories Commits $35 Million to Expand Malaysian Operations

  8/12/2013

• Ranbaxy Laboratories' Indian Facilities Under Scanner: Ghulam Nabi Azad

  8/7/2013

• Ranbaxy Laboratories Goes on Mass Retrenching Spree: Set to Fire 400 Employees in the Next Few Months

  7/9/2013

• Ranbaxy Laboratories, Another Bad FDA Report & the Missing Generic Diovan

  6/25/2013

• Apollo Pharmacy Halts Sale of Ranbaxy Laboratories Drugs

  6/10/2013

• More Trouble for Ranbaxy Laboratories as Drug Boycott to Continue

  5/29/2013

• Ranbaxy Laboratories Rumored to Cut One-Third of Global Sales Force, Mainly in U.S.: Source

  5/23/2013

• Ranbaxy Laboratories Announces Improved Business Standards and Quality Assurance Initiatives

  5/23/2013